Skip to content

Search

Showing results for "8"

Asthma medication reduces respiratory complications during tonsil surgery

A Perth study has shown that over-the-counter asthma medication before surgery can reduce respiratory complications during and after tonsillectomy surgery.

Launch of National Autism Guideline

Researchers from The Kids Research Institute Australia, working with the Autism CRC, have led the development of the National Guideline for the Assessment and Diagnosis of Autism Spectrum Disorder in Australia which was launched today.

Positive Family Foundations

Enhancing psychological wellbeing in families from pregnancy to infancy

Self-efficacy groups 2020

Perth Children’s Hospital’s Diabetes Service has released the dates for its self-efficacy groups for 2020.

Nine-year-old Beau cuts his curls to fight cancer

Meet Beau Jones. Beau is nine-years-old and lives in Eaton where he likes playing basketball and hanging out with his brothers. He’s also passionate about standing up to cancer!

Some heroes wear capes. Some heroes wear lab coats. And some heroes wear school uniforms, just like you!

Ten-year-old Isabelle decided to make and sell loom band bracelets to raise money for The Kids Research Institute Australia.

Science at Home: Build a lung model!

Have you ever wondered how your lungs work? Researchers from our Children’s Lung Health Team show you how to make a simple lung model by using common household items.

Pitch Perfect! Illuminate PitchFest 2023

Ten researchers from different areas took to the stage with a carefully crafted presentation and three-minute pitch, in efforts to spark the interest of 80 guests

Altered attainment of developmental milestones

Regression, including the loss of previously learned skills, such as hand function and communication skills, is one of the most suggestive features of Rett synd

EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses

High-grade gliomas including glioblastoma (GBM) and diffuse midline gliomas (DMG) represent the most lethal and aggressive brain cancers where current treatment modalities offer limited efficacy. Chimeric antigen receptor (CAR) T cell therapies have emerged as a promising strategy, boasting tumor-specific targeting and the unique ability to penetrate the blood-brain barrier.